Web Analytics

3 Latest Announced Rounds

  • $5,500,000
    Pre-Seed
    Technology, Information and Internet
    May 13th, 2025
  • $20,000,000
    Series A
    Computers and Electronics Manufacturing
    May 13th, 2025
  • $20,000,000
    Series A
    Computer & Network Security
    May 13th, 2025
$563.38M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Therini Bio, Inc.

start up
United States - South San Francisco, CA
  • 27/04/2023
  • Series A
  • $36,000,000

Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.


Related People

Michael QuigleyFounder

Michael Quigley United States - San Francisco Bay Area

N/A